Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Transcript signatures that predict outcome and identify targetable pathways in MYCN-amplified neuroblastoma

Published:2016-08-18 Issue:9 Volume:10 Page:1461-1472
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Hallett Robin M.,Seong Alex B.K.,Kaplan David R.,Irwin Meredith S.

Funder

Canadian Institute of Health Research

James Birrell Fund

Lilah's Fund for Neuroblastoma Research

Canadian Stem Cell Network

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference65 articles.

1. A 6-gene signature identifies four molecular subgroups of neuroblastoma;Abel;Cancer Cell Int,2011

2. Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification;Asgharzadeh;J. Natl. Cancer Inst,2006

3. Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma;Asgharzadeh;J. Clin. Oncol,2012

4. Chromosome 1p and 11q deletions and outcome in neuroblastoma;Attiyeh;N. Engl. J. Med,2005

5. A p53 drug response signature identifies prognostic genes in high-risk neuroblastoma;Barbieri;PLoS One,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA repair and replicative stress addiction in neuroblastoma;EJC Paediatric Oncology;2024-12

2. A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex;EMBO Reports;2024-06-28

3. Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review;Cancers;2024-02-16

4. A novel role for the peptidyl-prolylcis-transisomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex;2023-06-28

5. Development and Validation of a Five-RNA–Based Signature and Identification of Candidate Drugs for Neuroblastoma;Frontiers in Genetics;2021-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3